All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

71

Reset

71 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • TTI-101Phase 22 trials

    Tvardi Therapeutics, Incorporated · Hepatocellular Carcinoma, Idiopathic Pulmonary Fibrosis

  • VEGF antibodyPhase 22 trials

    Lepu Biopharma Co., Ltd. · Hepatocellular Carcinoma, Advanced Colorectal Cancer

  • WGI-0301Phase 22 trials

    Zhejiang Haichang Biotech Co., Ltd. · Advanced Hepatocellular Carcinoma (HCC), Hepato Cellular Carcinoma (HCC), Renal Cell Cancer

  • atilizumabPhase 21 trial

    Abbisko Therapeutics Co, Ltd · Hepatocellular Carcinoma

  • AZD5851Cell TherapyPhase 21 trial

    AstraZeneca · Hepatocellular Carcinoma

  • AZD9793Phase 21 trial

    AstraZeneca · Hepatocellular Carcinoma

  • BB102Phase 21 trial

    Broadenbio Ltd., Co. · Hepatocellular Carcinoma (HCC)

  • BI-1910Phase 21 trial

    BioInvent International AB · Solid Tumors, Non Small Cell Lung Cancer, Hepatocellular Carcinoma

  • CasdozokitugCHS-388Phase 21 trial

    Coherus Oncology, Inc. · Hepatocellular Carcinoma

  • Decoy20Phase 21 trial

    Indaptus Therapeutics, Inc · Solid Tumor, Adult, HCC - Hepatocellular Carcinoma, CRC (Colorectal Cancer)

  • E7386Phase 21 trial

    Eisai · Endometrial Neoplasms, Neoplasms, Carcinoma, Hepatocellular

  • FB-1603Phase 21 trial

    Febico Biomedical Corp. · Hepatocellular Carcinoma

  • FinotonlimabPhase 21 trial

    Sichuan Baili Pharmaceutical Co., Ltd. · Advanced Hepatocellular Carcinoma

  • HA131Phase 21 trial

    CSPC ZhongQi Pharmaceutical Technology Co., Ltd. · Advanced Hepatocellular Carcinoma (HCC)

  • HLX53Phase 21 trial

    Shanghai Henlius Biotech · Carcinoma, Hepatocellular

  • MDSY-1240Phase 21 trial

    Medsyn Biopharma, LLC · Triple-Negative Breast Cancer (TNBC), Gastric Cancer (GC), Gastric Cancer Adenocarcinoma Metastatic

  • MIV-818Phase 21 trial

    Medivir · Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Liver Metastases

  • RYZ801Phase 21 trial

    RayzeBio, Inc. · Hepatocellular Carcinoma (HCC)

  • SCG101Phase 21 trial

    SCG Cell Therapy Pte. Ltd. · Hepatitis B Virus Related Hepatocellular Carcinoma, Hepatocellular Carcinoma Recurrent

  • TB511Phase 21 trial

    Twinpig Biolab, Inc. · NSCLC, Prostate Cancer, Colorectal Cancer

  • VMD-102Single agentPhase 21 trial

    VM Discovery, Inc. · Hepatocellular Carcinoma (HCC), Metastatic Uveal Melanoma, Renal Cell Carcinoma (RCC)

NewerPage 2 of 2

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.